Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: Estimations from a disease model

Archives of Osteoporosis

Volumn 6, Issue 1-2, 2011, Pages 179-188

  Gauthier, Aline ^a,b,i   Kanis, John A ^c   Jiang, Yling ^a   Martin, Monique ^d   Compston, Juliet E ^e   Borgström, Fredrik ^f   Cooper, Cyrus ^g,h   McCloskey, Eugene V ^c  

^a Amaris   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d i3 Innovus   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ NONE   (United Kingdom)

Author keywords

Bone mineral density; Epidemiology; Fracture; Osteoporosis; T score; UK

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; OSTEOPENIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; UNITED KINGDOM; VERTEBRA FRACTURE;

EID: 84856084463     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-011-0063-y     Document Type: Article

References (40)

1. [No authors listed] (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646-650
2. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series no. 843. World Health Organization, Geneva, pp 1-129
3. Kanis JA; on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary healthcare level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK
4. van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517-522 (Pubitemid 33124293)
5. Department of Health and Human Services (2004) Bone Health and Osteoporosis: A Report of the Surgeon General. Department of Health and Human Services, Washington
6. Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3-S11 (Pubitemid 43152482)
7. Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307(6914):1248-1250
8. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK (2003) The components of excess mortality after hip fracture. Bone 32:468-473 (Pubitemid 39665705)
9. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15:108-112 (Pubitemid 38252423)
10. Burge R, Worley D, Johansen A, Bhattacharyya S, Bose U (2001) The cost of osteoporotic fractures in the UK: projections for 2000-2020. J Med Econ 4:51-62 (Pubitemid 32537253)
11. Johansen A, Evans RJ, Stone MD, Richmond PW, Lo SV, Woodhouse KW (1997) Fracture incidence in England and Wales: a study based on the population of Cardiff. Injury 28:655-660 (Pubitemid 28185117)
12. Gauthier A, Kanis JA, Martin M, Compston J, Borgström F, Cooper C, McCloskey E (2011) Development and validation of a disease model for postmenopausal osteoporosis. Osteoporos Int 22:771-780
13. Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, Johnston CC et al (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16-23 (Pubitemid 27053607)
14. Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417-427 (Pubitemid 32606468)
15. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375-382 (Pubitemid 38953182)
16. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468-489 (Pubitemid 28486716)
17. Klotzbuecher CM, Ross PD, Lansman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739 (Pubitemid 30174026)
18. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254-1259 (Pubitemid 26147662)
19. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, De Laet C et al (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669-674
20. Office for National Statistics, General Register Office for Scotland, and Northern Ireland Statistics and Research Agency. http://www.statistics.gov.uk. Accessed 26 October 2007
21. Government Actuary's Department, Projections database: 2006- based principal projections. http://www.gad.gov.uk/Demography% 20Data/Population/ index.aspx?y=2006&v=Principal. Accessed 20 October 2010
22. Singer BR, McLauchlan GJ, Robinson CM, Christie J (1998) Epidemiology of fractures in 15,000 adults: the influence of age and gender. J Bone Joint Surg Br 80:243-248
23. De Lusignan S, Valentin T, Chan T, HagueN,Wood O, van Vlymen J, Dhoul N (2004) Problems with primary care data quality: osteoporosis as an exemplar. Inform Prim Care 12:147-156 (Pubitemid 39534580)
24. NICE (National Institute for Clinical Excellence) (2008) Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. London. www.nice.org.uk. Accessed 16 November 2010
25. Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J (2005) A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 9:1-160
26. Kanis JA, Adams J, Borgstrom F, Cooper C, Jonsson B, Preedy D, Selby P, Compston J (2008) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42:4-15
27. Spector TD, Cooper C, Lewis AF (1990) Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ 300:1173-1174 (Pubitemid 20153712)
28. Balasegaram S, Majeed A, Fitz-Clarence H (2002) Trends in hospital admissions for fractures of the hip and femur in England, 1989-1990 to 1997-1998. J Public Health Med 23:11-17 (Pubitemid 32246296)
29. Icks A, Haastert B, Wildner M, Becker C, Meyer G (2008) Trend of hip fracture incidence in Germany 1995-2004: a populationbased study. Osteoporos Int 19:1139-1145
30. Kannus P, Niemi S, Parkkari J, Palvanen M, Vuori I, Järvinen M (2006) Nationwide decline in incidence of hip fracture. J Bone Miner Res 21:1836-1838 (Pubitemid 44851558)
31. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573-1579
32. Leslie WD, O'Donnell S, Jean S, Lagacé C, Walsh P, Bancej C, Morin S et al (2009) Trends in hip fracture rates in Canada. JAMA 302:883-889
33. Holt G, Khaw KT, Reid DM, Compston JE, Bhalla A, Woolf AD, Crabtree NJ et al (2002) Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry. Br J Radiol 75:736-742 (Pubitemid 35021386)
34. Noon E, Singh S, Cuzick J, Spector TD, Williams FM, Frost ML, Howell A, Harvie M, Eastell R, Coleman RE, Fogelman I, Blake GM, IBIS-II Bone Substudy (2010) Significant differences in UK and US female bone density reference ranges. Osteoporos Int 21:1871-1880
35. NICE (2008) National Institute for Clinical Excellence (NICE) technology appraisal guidance 160. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. http:// www.nice.org.uk/TA160. Accessed 17 November 2010
36. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group Case finding for the management of osteoporosis with FRAX®-Assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395.
37. Erratum Osteoporos Int 2009;20:499-502
38. Compston J, Cooper A, Cooper C et al (2009) National Osteoporosis Guideline Group (NOGG). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105-108
39. World Health Organization (2004) Burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates.
40. The World Health Report 2004: changing history. World Health Organization, Geneva, pp 126-131